CIK 0001672619
- Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811523849
- Phone
- +1 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at an average $23.18 ($278,210)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $23.18 ($98,530)
- 4 Planned sale Director sold 1,270 shares at $23.74 ($30,150)
- 4 Open-market sale Director sold 1,033,300 shares at $22.14 ($22,877,262)
- 4 Open-market sale Director sold 1,033,300 shares at $22.14 ($22,877,262)
- 4 Planned sale CHIEF OPERATING OFFICER sold 1,107 shares at $25.00 ($27,675)
- 4 Planned sale CHIEF OPERATING OFFICER sold 260 shares at $25.06 ($6,515)
- 4 Planned sale CHIEF OPERATING OFFICER sold 4,875 shares at $22.72 ($110,769)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.50 ($22,500)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 12,000 shares at an average $17.92 ($214,988)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $16.97 ($55,165)
- 4 Planned sale PRESIDENT AND CEO sold 12,000 shares at $16.89 ($202,700)
- 4 Planned sale CHIEF OPERATING OFFICER sold 17,500 shares at $25.03 ($438,099)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 30,000 shares at $25.04 ($751,332)
- 4 Planned sale PRESIDENT AND CEO sold 47,709 shares at $25.04 ($1,194,700)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 14,000 shares at an average $24.72 ($346,149)
- 4 Planned sale Director sold 6,964 shares at an average $24.11 ($167,888)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 20,000 shares at $25.07 ($501,478)
- 4 Planned sale Director sold 67,000 shares at an average $23.36 ($1,564,812)
- 4 Derivatives Options or other derivatives
Page 9 of 20 · 383 filings